UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035160
Receipt number R000040074
Scientific Title Study of long-term changes and related factors for size, site, age, gender difference of ruptured cerebral aneurysm, cerebral vasospasm / delayed cerebral ischemia, outcome, and treatment method
Date of disclosure of the study information 2018/12/06
Last modified on 2023/11/06 09:03:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of long-term changes and related factors for size, site, age, gender difference of ruptured cerebral aneurysm, cerebral vasospasm / delayed cerebral ischemia, outcome, and treatment method

Acronym

Research on long-term changes and related factors for ruptured cerebral aneurysm

Scientific Title

Study of long-term changes and related factors for size, site, age, gender difference of ruptured cerebral aneurysm, cerebral vasospasm / delayed cerebral ischemia, outcome, and treatment method

Scientific Title:Acronym

Research on long-term changes and related factors for ruptured cerebral aneurysm

Region

Japan


Condition

Condition

subarachnoid hemorrhage, ruptured cerebral aneurysm

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the risk factors of ruptured cerebral aneurysm by the investigation for the change of size, site, age, gender difference, cerebral vasospasm / delayed cerebral ischemia, treatment method, and outcome

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

modified Rankin scale at discharge, 6 month after onset

Key secondary outcomes

change of size, site, age, gender difference, cerebral vasospasm / delayed cerebral ischemia, treatment method for ruptured cerebral aneurysm


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

aneurysmal subarachnoid hemorrhage cases diagnosed by CT, MRI, or cerebrospinal fluid study, and subarachnoid hemorrhage cases caused by ruptured cerebral aneurysm confirmed by CT angiography, MR angiography, or digital subtraction angiography

Key exclusion criteria

unknown subarachnoid hemorrhage, subarachnoid hemorrhage without ruptured cerebral aneurysm, subarachnoid hemorrhage without any imaging study

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name Fusao
Middle name
Last name Ikawa

Organization

Shimane Prefectural Central Hospital

Division name

Department of Neurosurgery

Zip code

693-8555

Address

4-1-1 Himebara, Izumo City, Shimane,

TEL

0853-22-5111

Email

fikawa-nsu@umin.ac.jp


Public contact

Name of contact person

1st name Fusao
Middle name
Last name Ikawa

Organization

Shimane Prefectural Central Hospital

Division name

Department of Neurosurgery

Zip code

693-8555

Address

4-1-1 Himebara, Izumo, Shimane

TEL

0853225111

Homepage URL


Email

fikawa-nsu@umin.ac.jp


Sponsor or person

Institute

Shimane Prefectural Central Hospital
Department of Neurosurgery
4-1-1 Himebara, Izumo City, Shimane,

Institute

Department

Personal name



Funding Source

Organization

Shimane Prefectural Central Hospital
Department of Neurosurgery
4-1-1 Himebara, Izumo City, Shimane,

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shimane Prefectural Central Hospital, Clinical Research and Trial Management Center

Address

4-1-1 Himebara, izumo, shimane

Tel

0853225111

Email

chiken@spch.izumo.shimane.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 11 Month 01 Day

Date of IRB

2018 Year 11 Month 01 Day

Anticipated trial start date

2018 Year 11 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

under making paper


Management information

Registered date

2018 Year 12 Month 06 Day

Last modified on

2023 Year 11 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040074


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name